Cited by 56Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsDNA Repair Mechanisms

A neuronal DNA damage response is detected at the earliest stages of A lzheimer's neuropathology and correlates with cognitive impairment in the M edical R esearch C ouncil's C ognitive F unction and A geing S tudy ageing brain cohort

Open access
Simpson, Julie E., Ince, Paul G., Matthews, Fiona E., Shaw, Pamela J., Heath, Paul R., Brayne, Carol, Garwood, Claire, Higginbottom, Adrian +2 more·2015·Neuropathology and Applied Neurobiology

Abstract

Aims: Population‐based studies have shown that approximately 20% of the ageing population (aged 65 years and over) with dementia have little or no classical A lzheimer‐type neuropathology. Cumulative DNA damage and a reduced capacity of DNA repair may result in neuronal dysfunction and contribute to cognitive impairment independent of A lzheimer‐type pathology in the ageing brain. Methods: We investigated expression of the DNA damage response (DDR)‐associated molecules γH2AX and DNA‐PKcs using immunohistochemistry and western blotting, and senescence‐associated β‐galactosidase in the frontal association neocortex of cases with low levels of A lzheimer‐type pathology (B raak & B raak stage 0–II), and explored their relationship to cognitive impairment in a population‐representative sample from the M edical R esearch C ouncil's C ognitive F unction and A geing Study cohort. Results: Increases in both γH2AX+ (rs = −0.36, P = 0.025) and DNA‐PKcs+ (rs = −0.39, P = 0.01) neuronal counts were associated with a lower M ini‐M ental S tate E xamination score. Increasing levels of senescence associated‐β‐gal+ pyramidal neurones were weakly associated with the total number of DNA‐PKcs+ neurones (P = 0.08), but not with traditional senescence‐associated signalling molecules, including p53 and p16. Conclusion: The association between the neuronal DDR and cognitive impairment, independent of AD pathology in the ageing brain, may be suggestive of a causal link via neuronal dysfunction.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/nan.12202

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DSB marker proteins correlate with cognitive impairment in individuals with low levels of amyloid and tau pathology.

    “Similarly, DSB marker proteins correlate with cognitive impairment in individuals with low levels of amyloid and tau pathology (Simpson et al, 2015).”

    From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Simpson et al, 2015

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Simpson, J. E., Ince, P. G., Matthews, F. E., Shaw, P. J., Heath, P. R., Brayne, C., Garwood, C., Higginbottom, A., Wharton, S. B., & MRC Cognitive Function and Ageing Neuropathology Study Group
Affiliations
  • University of Sheffield (GB)
  • University of Cambridge (GB)
Corresponding author
Wharton, Stephen B.
Venue
Neuropathology and Applied Neurobiology
Publisher
Wiley
Published
2015-04-23
Volume
41
Issue
4
Pages
483-496
ISSN
  • 0305-1846 (ISSN-L)
  • 1365-2990
OpenAlex
W1494866131
Cited by
56
References
53
Citations by year
2026: 4 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 4 · 2020: 8 · 2019: 7 · 2018: 4 · 2017: 4 · 2016: 5 · 2015: 2
FWCI
2.80
Type
journal article
Language
en
Open access
Locations
  • Neuropathology and Applied Neurobiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
Funders
  • Department of Health
  • Medical Research Council (MRC/G9901400, MRC U.1052.00.0013, MR/J004 308/1)
  • UKNIHR Biomedical Research Centre for Ageing and Age-related Disease Award
  • NIHR Cambridge Biomedical Research Centre
  • Cambridgeshire and Peterborough NIHR CLAHRC
  • Nottingham University Hospitals NHS Trust
  • University of Sheffield
  • Sheffield Teaching Hospitals NHS Foundation Trust
  • Oxford Biomedical Research Centre
  • Walton Centre NHS Foundation Trust, Liverpool
  • Neurocare
  • Alzheimer's Research UK (ART-PG2010-5)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Keywords
Alzheimer's disease, DNA damage response, γH2AX, DNA-PKcs, cognitive impairment, neuronal senescence, senescence-associated β-galactosidase, Braak stages, brain aging, dementia, frontal association cortex, pyramidal neurons, neuronal dysfunction
MeSH terms
Aged, Aged, 80 and over, Aging, Alzheimer Disease, Brain, DNA Damage, Female, Histones, Humans, Male, Neurons, Neuropsychological Tests, Protein Kinases, Cohort Studies, Pyramidal Cells, Oxidative Stress

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review